Balchem Corporation (NASDAQ:BCPC) Position Increased by GAMMA Investing LLC

GAMMA Investing LLC raised its position in Balchem Corporation (NASDAQ:BCPC) by 22.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,068 shares of the basic materials company’s stock after purchasing an additional 196 shares during the quarter. GAMMA Investing LLC’s holdings in Balchem were worth $177,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Covestor Ltd lifted its position in shares of Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company’s stock worth $26,000 after buying an additional 76 shares during the last quarter. Federated Hermes Inc. acquired a new position in shares of Balchem during the 4th quarter valued at about $33,000. Versant Capital Management Inc increased its holdings in shares of Balchem by 534.2% during the 1st quarter. Versant Capital Management Inc now owns 241 shares of the basic materials company’s stock valued at $40,000 after acquiring an additional 203 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Balchem by 230.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company’s stock valued at $106,000 after acquiring an additional 450 shares in the last quarter. Finally, Huntington National Bank lifted its holdings in Balchem by 30.9% in the 4th quarter. Huntington National Bank now owns 661 shares of the basic materials company’s stock worth $108,000 after purchasing an additional 156 shares during the last quarter. 87.91% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

BCPC has been the topic of several analyst reports. Wall Street Zen downgraded Balchem from a “buy” rating to a “hold” rating in a report on Wednesday, May 21st. HC Wainwright set a $180.00 price objective on shares of Balchem and gave the stock a “buy” rating in a report on Monday, April 28th.

Balchem Trading Up 1.1%

Balchem stock opened at $164.92 on Friday. Balchem Corporation has a 52 week low of $145.70 and a 52 week high of $186.03. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.40 and a current ratio of 2.44. The firm has a market capitalization of $5.38 billion, a PE ratio of 39.55, a PEG ratio of 3.56 and a beta of 0.89. The business’s 50-day simple moving average is $163.40 and its 200-day simple moving average is $163.08.

Balchem (NASDAQ:BCPC) last released its earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.25 by ($0.03). Balchem had a net margin of 14.16% and a return on equity of 12.01%. The business had revenue of $250.52 million during the quarter, compared to analyst estimates of $245.70 million. During the same period last year, the business earned $1.03 EPS. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. Equities research analysts forecast that Balchem Corporation will post 4.64 earnings per share for the current year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.